See also this year's filing and all EDGAR filings for this company.
PDF Report 0001434418_2019_Constellation_Pharmaceuticals_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001434418, Constellation Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 117,303,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,210,000 |
| 3 | remainder_Assets | 425,000 |
| 4 | LiabilitiesCurrent | 14,660,000 |
| 5 | LiabilitiesNoncurrent | 2,000 |
| 6 | remainder_Liabilities | 118,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 12,475,000 |
| 9 | ResearchAndDevelopmentExpense | 48,769,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 1,319,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 118,938,000 |
| 1 | Liabilities | 14,780,000 |
| 2 | Expenses | 61,244,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 104,158,000 |
| 5 | NetIncome | -59,925,000 |
| 6 | ComprehensiveNetIncome | -59,925,000 |
| 7 | BaseVar | 98,140,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.50 |
| 9 | EconomicCapitalRatio | 3.36 |
Edgar->Model Mapping
Feature Distribution
